Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
HKEX:2607
Shanghai Pharmaceuticals Holding Co (2607) Stock Price & Analysis
2 Followers
2607 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$10.18 - HK$14.56
Previous CloseHK$11.8
Volume2.36M
Average Volume (3M)3.16M
Market Cap
HK$60.79B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.5
Beta0.52
Next Earnings
Aug 30, 2024EPS Estimate
HK$0.4Next Dividend Ex-Date
Jul 18, 2024Dividend Yield5.44%
Share Statistics
EPS (TTM)1.12
Shares Outstanding919,072,704
10 Day Avg. Volume3,675,000
30 Day Avg. Volume3,156,869
Standard Deviation0.07
R-Squared0.35
Alpha-0.00124
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.49Price Target Upside48.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Shanghai Pharmaceuticals Holding Co News
PremiumCompany Announcements
Shanghai Pharmaceuticals Unveils Updated Board Structure
PremiumCompany Announcements
Shanghai Pharma Announces Year-End Cash Dividend
PremiumCompany Announcements
Shanghai Pharmaceuticals Announces AGM OutcomesPremiumCompany Announcements
Shanghai Pharma Schedules Annual General Meeting
PremiumCompany Announcements
Shanghai Pharma Announces Upcoming AGM
PremiumCompany Announcements
Shanghai Pharma Declares Year-End Cash Dividend
PremiumCompany Announcements
Shanghai Pharma Nominates New Board Member
PremiumCompany Announcements
Shanghai Pharma Announces Board ResignationOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
5.03% Mutual Funds
7.83% Other Institutional Investors
87.14% Public Companies and
Individual Investors
2607 FAQ
What was Shanghai Pharmaceuticals Holding Co Ltd Class H’s price range in the past 12 months?
Shanghai Pharmaceuticals Holding Co Ltd Class H lowest stock price was HK$10.18 and its highest was HK$14.56 in the past 12 months.
What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s market cap?
Currently, no data Available
When is Shanghai Pharmaceuticals Holding Co Ltd Class H’s upcoming earnings report date?
Shanghai Pharmaceuticals Holding Co Ltd Class H’s upcoming earnings report date is Aug 30, 2024 which is in 44 days.
How were Shanghai Pharmaceuticals Holding Co Ltd Class H’s earnings last quarter?
Shanghai Pharmaceuticals Holding Co Ltd Class H released its earnings results on Apr 26, 2024. The company reported HK$0.452 earnings per share for the quarter, the consensus estimate of HK$0.452 by HK$0.
Is Shanghai Pharmaceuticals Holding Co Ltd Class H overvalued?
According to Wall Street analysts Shanghai Pharmaceuticals Holding Co Ltd Class H’s price is currently Undervalued.
Does Shanghai Pharmaceuticals Holding Co Ltd Class H pay dividends?
Shanghai Pharmaceuticals Holding Co Ltd Class H pays a Annually dividend of HK$0.44 which represents an annual dividend yield of 5.44%. See more information on Shanghai Pharmaceuticals Holding Co Ltd Class H dividends here
What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s EPS estimate?
Shanghai Pharmaceuticals Holding Co Ltd Class H’s EPS estimate is HK$0.4.
How many shares outstanding does Shanghai Pharmaceuticals Holding Co Ltd Class H have?
Shanghai Pharmaceuticals Holding Co Ltd Class H has 919,072,700 shares outstanding.
What happened to Shanghai Pharmaceuticals Holding Co Ltd Class H’s price movement after its last earnings report?
Shanghai Pharmaceuticals Holding Co Ltd Class H reported an EPS of HK$0.452 in its last earnings report, expectations of HK$0.452. Following the earnings report the stock price went up 0.891%.
Which hedge fund is a major shareholder of Shanghai Pharmaceuticals Holding Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:2607
---
Shanghai Pharmaceuticals Holding Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.77%
12-Months-Change
Fundamentals
Return on Equity
5.39%
Trailing 12-Months
Asset Growth
0.33%
Trailing 12-Months
Company Description
Shanghai Pharmaceuticals Holding Co Ltd Class H
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
---
2607 Stock 12 Month Forecast
Average Price Target
HK$17.49
▲(48.18% Upside)
Technical Analysis
Takeda Pharmaceutical Company
―
Johnson & Johnson
―
AstraZeneca
―
Karyopharm Therapeutics
―
Shanghai Pharmaceuticals Holding Co
―
Best Analysts Covering 2607
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+4.95%
reiterated a buy rating last month
Copying Laurence Tam's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.95% per trade.
---